BRIEF-AstraZeneca announces positive results for new antibiotic

LONDON Tue Aug 19, 2014 2:21am EDT

Related Topics

LONDON Aug 19 (Reuters) - AstraZeneca Plc

* Announces positive top-line results from phase III programme of CAZ-AVI

* AstraZeneca today announced positive top-line results from RECLAIM-1 and RECLAIM-2, the pivotal Phase III studies investigating the potential of the antibiotic ceftazidime-avibactam (CAZ-AVI) as a treatment for hospitalised adult patients with complicated intra-abdominal infections. Source text for Eikon: Further company coverage: (Editing by Neil Maidment)